BRCA1 pathogenic variants expose women to a lifetime risk of 72% (95% confidence interval [CI] 65–79%) for BC, while BRCA2 pathogenic variant carriers face a risk of 69% (95% CI 61–77%) [1]. The gene discussed is BRCA2; the disease is breast cancer.